Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    Ravi Salgia, editor.
    Summary: This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patients genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.

    Contents:
    1. EGFR
    2. ALK
    3. ROS1
    4. B-RAF
    5. MET
    6. HER2
    7. NTRK
    8. SCLC
    9. Complexities of the Lung Tumor Microenvironment
    10. KRAS
    11. Targeting Epigenetic Regulators in Cancer to Overcome Targeted Therapy Resistance.
    Digital Access Springer 2019
  • Book
    Edwin M. Bridges ; with the assistance of Barry Groves.
    Print c1990
  • Article
    Scott FW, Forsdyke DR.
    Biochem J. 1978 Mar 15;170(3):545-9.
    The rate of DNA synthesis is exponentially growing cells was determined by isotopedilution analysis of the incorporation of [me-3H]thymidine. Thymidine concentrations greater than 7 micrometer were used so that the rate-limiting step governing incorporation would be at the level of DNA polymerase rather than at the level of thymidine kinase [Sjostrom & Forsdyke (1974) Biochem. J. 138, 253-262]. In early exponential phase the rate determined by isotope-dilution analysis closely correlated with the rates calculated either from growth curves or from known cell-cycle parameters. However, in late-exponential phase the rate calculated from the growth curve was less than that determined by isotope-dilution analysis. We conclude that, under certain conditions, the pool-corrected rate of incorporation of [me-3H]thymidine, as determined by isotope-dilution analysis, can accurately reflect the rate of DNA synthesis. Discrepancies between the observed rate of DNA synthesis and increase in cell number could reflect an exponential degeneration of post-S-phase cells.
    Digital Access Access Options